• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用酸碱超增溶(ABS)原理开发具有快速药物释放、高药物-聚合物混溶性和降低打印温度的 FDM 3D 打印片剂。

Development of FDM 3D-printed tablets with rapid drug release, high drug-polymer miscibility and reduced printing temperature by applying the acid-base supersolubilization (ABS) principle.

机构信息

College of Pharmacy and Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, NY 11439, USA.

College of Pharmacy and Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, NY 11439, USA.

出版信息

Int J Pharm. 2021 May 1;600:120524. doi: 10.1016/j.ijpharm.2021.120524. Epub 2021 Mar 26.

DOI:10.1016/j.ijpharm.2021.120524
PMID:33775724
Abstract

Some of the major issues with the development of FDM 3D printed tablets are slow drug release, lack of drug-polymer miscibility, high processing temperature, and poor printability. In this investigation, these issues were addressed by using a novel physicochemical principle called acid-base supersolubilization (ABS) previously developed in our laboratory. The aqueous solubility of a basic drug, haloperidol, was increased to ~300 mg/g of solution by adding glutaric acid, and, upon drying, the concentrated solutions produced amorphous materials. Similar amorphous systems could also be produced by heating haloperidol-glutaric acid mixtures. Filaments for 3D printing were prepared by melt extrusion of formulations containing 15% w/w haloperidol and 10.5% glutaric acid (1:2 M ratio) along with 74.5% polymers, such as Kollidon® VA64 alone or its mixtures with Affinisol™ 15cP. Filaments could be extruded and printed at low temperatures of 115 and 120 °C, respectively. Haloperidol was fully miscible in the formulations because of the acid-base interaction and formed amorphous systems even at higher drug loads. Although filaments of haloperidol-Kollidon® VA64 mixtures by themselves cannot be printed, the printability of formulation improved such that those containing glutaric acid were printable. Drug release rates from the formulations at pH 2 and 6.8 were rapid and complete.

摘要

FDM 3D 打印片剂发展存在一些主要问题,包括药物释放缓慢、缺乏药物-聚合物混溶性、加工温度高和可印刷性差。在这项研究中,我们使用了一种新的物理化学原理——酸碱超增溶(ABS)来解决这些问题,该原理是我们实验室之前开发的。碱性药物氟哌啶醇的水溶解度通过添加戊二酸增加到约 300mg/g 的溶液,干燥后,浓缩溶液产生无定形物质。通过加热氟哌啶醇-戊二酸混合物也可以产生类似的无定形系统。用于 3D 打印的长丝是通过挤出含有 15%w/w 氟哌啶醇和 10.5%戊二酸(1:2 M 比)以及 74.5%聚合物(如 Kollidon® VA64 单独或与 Affinisol™ 15cP 的混合物)的制剂来制备的。长丝可以在 115 和 120°C 的低温下挤出和打印。由于酸碱相互作用,氟哌啶醇在制剂中完全混溶,即使在较高的药物负载下也形成无定形系统。尽管氟哌啶醇-Kollidon® VA64 混合物本身的长丝不能打印,但制剂的可印刷性得到了改善,以至于含有戊二酸的制剂可以打印。在 pH 2 和 6.8 时,制剂的药物释放速率很快且完全。

相似文献

1
Development of FDM 3D-printed tablets with rapid drug release, high drug-polymer miscibility and reduced printing temperature by applying the acid-base supersolubilization (ABS) principle.应用酸碱超增溶(ABS)原理开发具有快速药物释放、高药物-聚合物混溶性和降低打印温度的 FDM 3D 打印片剂。
Int J Pharm. 2021 May 1;600:120524. doi: 10.1016/j.ijpharm.2021.120524. Epub 2021 Mar 26.
2
Improving drug release rate, drug-polymer miscibility, printability and processability of FDM 3D-printed tablets by weak acid-base interaction.通过酸碱弱相互作用提高 FDM 3D 打印片剂的药物释放速率、药物-聚合物混溶性、可印刷性和可加工性。
Int J Pharm. 2023 Feb 5;632:122542. doi: 10.1016/j.ijpharm.2022.122542. Epub 2022 Dec 22.
3
Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.熔融沉积建模的快速药物释放 3D 打印片剂的配方:用于药物释放、药物-聚合物混溶性和可印刷性筛选的聚合物。
J Pharm Sci. 2018 Jan;107(1):390-401. doi: 10.1016/j.xphs.2017.10.021. Epub 2017 Oct 21.
4
Development of 3D Printed Tablets by Fused Deposition Modeling Using Polyvinyl Alcohol as Polymeric Matrix for Rapid Drug Release.利用聚乙烯醇作为聚合基质的熔融沉积成型法制备 3D 打印片剂以实现快速药物释放。
J Pharm Sci. 2020 Apr;109(4):1558-1572. doi: 10.1016/j.xphs.2020.01.015. Epub 2020 Jan 29.
5
An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.一项关于使用聚合物共混物来改善通过熔融沉积建模(FDM)3D打印制备的药物固体分散体的可印刷性并调节其药物释放的研究。
Eur J Pharm Biopharm. 2016 Nov;108:111-125. doi: 10.1016/j.ejpb.2016.08.016. Epub 2016 Sep 2.
6
Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.释放调节剂在熔融沉积成型(FDM)3D 打印片剂中调节药物释放的作用。
Int J Pharm. 2021 Mar 15;597:120315. doi: 10.1016/j.ijpharm.2021.120315. Epub 2021 Feb 1.
7
Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.热敏药物的低温熔融沉积成型(FDM)3D 打印。
Int J Pharm. 2018 Jul 10;545(1-2):144-152. doi: 10.1016/j.ijpharm.2018.04.055. Epub 2018 Apr 26.
8
Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.重点关注工业相关性的速释(IR)3D打印口服剂型的开发。
Eur J Pharm Sci. 2020 Dec 1;155:105558. doi: 10.1016/j.ejps.2020.105558. Epub 2020 Sep 16.
9
Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary.快速溶解的熔融沉积成型3D打印片剂开发中的挑战、现状及新兴策略:综述与评论
ADMET DMPK. 2023 Jan 1;11(1):33-55. doi: 10.5599/admet.1622. eCollection 2023.
10
Tailoring immediate release FDM 3D printed tablets using a quality by design (QbD) approach.采用质量源于设计(QbD)方法定制即时释放 FDM 3D 打印片剂。
Int J Pharm. 2021 Apr 15;599:120402. doi: 10.1016/j.ijpharm.2021.120402. Epub 2021 Feb 26.

引用本文的文献

1
Amorphization of Albendazole Using Organic Acid-based Solid Dispersions for Improved Dissolution: A Solvent-free Approach.使用基于有机酸的固体分散体使阿苯达唑非晶化以改善溶解性能:一种无溶剂方法。
AAPS PharmSciTech. 2025 Sep 11;26(7):228. doi: 10.1208/s12249-025-03223-3.
2
Kinetics of Phase Transitions in Amorphous Carbamazepine: From Sub- Structural Relaxation to High-Temperature Decomposition.非晶态卡马西平的相变动力学:从亚结构弛豫到高温分解
Int J Mol Sci. 2025 Jun 26;26(13):6136. doi: 10.3390/ijms26136136.
3
Effects of Different Weak Small Organic Acids on Clofazimine Solubility in Aqueous Media.
不同弱小分子有机酸对氯法齐明在水相介质中溶解度的影响
Pharmaceutics. 2024 Dec 2;16(12):1545. doi: 10.3390/pharmaceutics16121545.
4
Understanding the Interaction of Thermal, Rheological, and Mechanical Parameters Critical for the Processability of Polyvinyl Alcohol-Based Systems during Hot Melt Extrusion.理解热熔挤出过程中对基于聚乙烯醇的体系加工性能至关重要的热、流变和机械参数之间的相互作用。
Pharmaceutics. 2024 Mar 28;16(4):472. doi: 10.3390/pharmaceutics16040472.
5
3D printing processes in precise drug delivery for personalized medicine.3D 打印在精准药物输送中的应用——个性化医疗的新途径。
Biofabrication. 2024 Apr 17;16(3). doi: 10.1088/1758-5090/ad3a14.
6
Rising role of 3D-printing in delivery of therapeutics for infectious disease.3D 打印在传染病治疗药物传递中的作用不断提升。
J Control Release. 2024 Feb;366:349-365. doi: 10.1016/j.jconrel.2023.12.051. Epub 2024 Jan 8.
7
Diverse Applications of Three-Dimensional Printing in Biomedical Engineering: A Review.三维打印在生物医学工程中的多样应用:综述
3D Print Addit Manuf. 2023 Oct 1;10(5):1140-1163. doi: 10.1089/3dp.2022.0281. Epub 2023 Oct 10.
8
Thermal degradation of Affinisol HPMC: Optimum Processing Temperatures for Hot Melt Extrusion and 3D Printing.阿菲尼索尔 HPMC 的热降解:热熔挤出和 3D 打印的最佳加工温度。
Pharm Res. 2023 Sep;40(9):2253-2268. doi: 10.1007/s11095-023-03592-z. Epub 2023 Aug 23.
9
Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary.快速溶解的熔融沉积成型3D打印片剂开发中的挑战、现状及新兴策略:综述与评论
ADMET DMPK. 2023 Jan 1;11(1):33-55. doi: 10.5599/admet.1622. eCollection 2023.
10
Three-Dimensional Printing Technologies for Drug Delivery Applications: Processes, Materials, and Effects.用于药物递送应用的三维打印技术:工艺、材料及效果
Int J Bioprint. 2022 Oct 20;8(4):622. doi: 10.18063/ijb.v8i4.622. eCollection 2022.